STRATA Skin Sciences Reports Renewed Partnerships with Dermatology Clinics

STRATA Skin Sciences

HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) has announced the reintegration of six XTRAC® laser devices into dermatology clinics across the United States in the first quarter of 2024. These clinics, referred to as “comebacks” by the company, had previously terminated their partnership with STRATA but have now opted to rejoin the company’s partner program, signaling a renewed trust in STRATA’s offerings.

The comeback clinics, including notable names such as Henry Ford Health System in Detroit, Integrated Dermatology Group, and several practices from the Schweiger Dermatology Group, represent a significant reassessment of STRATA’s value proposition by these healthcare providers. The decision for these clinics to return to STRATA’s fold underlines a recognition of the benefits and effectiveness of the XTRAC® system alongside STRATA’s partnership model.

Dr. Dolev Rafaeli, President and CEO of STRATA Skin Sciences, highlighted the importance of these reestablished partnerships. “These comebacks are a testament to the comparative advantages and value our XTRAC® laser devices and partner program offer,” remarked Rafaeli. He emphasized that the return of these clinics not only serves as a strong endorsement of STRATA’s program but also as a vital component of the company’s strategy to enhance device utilization and increase revenue per device through targeted marketing efforts and customer re-engagement strategies.

This movement back to STRATA by previously detached clinics could reflect broader trends within dermatological care, particularly in the treatment of chronic skin conditions. The XTRAC® laser technology, known for its efficacy in treating psoriasis, vitiligo, and other skin diseases, combined with a supportive partner program, presents an attractive package for dermatology clinics aiming to provide top-tier patient care.

READ:  Mike Thomson Named Next CEO of Unisys

For the broader dermatology market, STRATA’s announcement signals a competitive landscape where technology and partnership terms play crucial roles in forging long-term relationships between medical device companies and healthcare providers. This scenario underscores the necessity for continuous innovation and customer service excellence in maintaining and expanding a presence in specialized medical fields.

STRATA’s strategic focus on recapturing lapsed customers while fostering the growth of its installed base through direct-to-consumer marketing initiatives positions the company for potential growth in service utilization and revenue per device, reflecting an optimistic outlook for its operational and financial performance in 2024 and beyond.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.